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Growth factor binding to EGFR drives conforma-
tional changes that promote homodimerization and
transphosphorylation, followed by adaptor recruit-
ment, oligomerization, and signaling through Ras.
Whether specific receptor conformations and oligo-
merization states are necessary for efficient activa-
tion of Ras is unclear. We therefore evaluated the
sufficiency of a phosphorylated EGFR dimer to acti-
vate Ras without growth factor by developing a
chemical-genetic strategy to crosslink and ‘‘trap’’
full-length EGFR homodimers on cells. Trapped di-
mers become phosphorylated and recruit adaptor
proteins at stoichiometry equivalent to that of EGF-
stimulated receptors. Surprisingly, these phosphory-
lated dimers do not activate Ras, Erk, or Akt. In the
absence of EGF, phosphorylated dimers do not
further oligomerize or reorganize on cell membranes.
These results suggest that a phosphorylated EGFR
dimer loaded with core signaling adapters is not suf-
ficient to activate Ras and that EGFR ligands
contribute to conformational changes or receptor dy-
namics necessary for oligomerization and efficient
signal propagation through the SOS-Ras-MAPK
pathway.INTRODUCTION
Epidermal growth factor receptor (EGFR) is a broadly expressed
receptor tyrosine kinase frequently mutated or overexpressed in
cancer. The steps of EGFR activation by ligands such as EGFCell
This is an open access article under the CC BY-Nhave been extensively studied. Biochemical, imaging, and
structural evidence support a model wherein monomers of
EGFR are inactive and in equilibrium with a population of inac-
tive dimers (Chung et al., 2010; Jura et al., 2009). Binding of
EGF stabilizes receptor conformations that expose an extracel-
lular dimerization interface, triggering accumulation of active
EGFR dimers (Ferguson et al., 2003; Ogiso et al., 2002). One
intracellular kinase then allosterically activates the other, result-
ing in phosphorylation of C-terminal tyrosines (Zhang et al.,
2006) (Figure 1A). Phosphorylated tyrosines recruit signaling
adapters such as Shc, Grb2, and SOS, which stimulate a variety
of downstream pathways (Margolis et al., 1989). Among these,
the Ras-MAPK (mitogen-activated protein kinase) pathway is a
particularly important regulator of cell behaviors such as prolif-
eration and migration.
The formation of phosphorylated EGFR dimers is generally
considered sufficient to initiate Ras signaling because the di-
mers recruit the Ras-GEF (guanine nucleotide exchange factor)
SOS to the membrane, and membrane-localized SOS is suffi-
cient to activate Ras under a variety of conditions (Aronheim
et al., 1994; Christensen et al., 2016; Toettcher et al., 2013).
However, conflicting observations raise questions regarding
whether a phosphorylated dimer is a competent signaling
unit, sufficient to activate Ras, in the absence of EGF. For
example, dimerization of a chimeric receptor’s intracellular
domains with rapamycin derivatives was sufficient to induce
EGFR phosphorylation and downstream Erk phosphorylation
(Muthuswamy et al., 1999). In contrast, dimerization of EGFR
on cancer cell lines with therapeutic antibodies resulted in
phosphorylated EGFR but no Erk phosphorylation (Yoshida
et al., 2008). While these examples varied greatly in experi-
mental design—for instance, the antibodies specifically tar-
geted EGFR’s extracellular domain and locked EGFR dimers
in an inactive conformation (Li et al., 2005), whereas the
chimeric EGFR had its extracellular domain replaced with theReports 22, 2593–2600, March 6, 2018 ª 2018 The Authors. 2593
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Decoupling EGFR Dimerization
and Transphosphorylation from Other EGF-
Induced Conformational and Spatial
Changes
(A) EGFR exists in a tethered monomer or an
inactive dimer formation. Upon EGF binding, it
adopts an extended dimer conformation and un-
dergoes auto-transphosphorylation. Phosphory-
lated dimers recruit adaptor proteins to EGFR, re-
sulting in activation of the Ras-MAPK pathway.
(B) EGF binding to EGFR also results in rapid
changes in spatial organization frommonomers (i) to
dimers (ii); to higher order multimers and nanoscale
clusters (iii-iv); to micron scale clusters in clathrin-
coated pits (v); and, finally, to endosomes (vi).
(C) A chemical genetic system utilizing a SNAP-tag
on the N terminus of full-length EGFR and BG-
modified DNA dimers as crosslinkers.
(D) Representative western blot of lysates from
cells treated with 8 nM EGF or 2 mM (DNA-BG)2. To
maintain DNA hybridization, SDS-PAGE samples
were not boiled. EGFR dimers (d) and monomers
(m) are indicated with arrows.transmembrane and extracellular domain of p75 Neurotrophin
receptor—it remains difficult to rationalize how the phosphory-
lated intracellular domains could be signaling competent in one
study but not in another.
A possible resolution of this conundrum is the requirement for
a specific tertiary or quaternary structure beyond the dimer, pro-
moted by EGF binding, to efficiently activate Ras. Upon EGF
binding, dimers undergo rapid spatial rearrangement into oligo-
mers and nanoscale clusters (Figure 1B) (Ariotti et al., 2010;
Clayton et al., 2008; Ichinose et al., 2004; Saffarian et al., 2007;
van Lengerich et al., 2017), and these oligomers may promote
downstream signaling (Huang et al., 2016; Kozer et al., 2013;
Needham et al., 2016). However, because oligomerization and
signaling changes occur on a similar timescale, it remains un-
clear whether specific spatial intermediates are a cause or
consequence of downstream signaling.
Wesought todeterminewhether a phosphorylatedEGFRdimer
is sufficient to activateRas signalingwithout EGF. This question is
challenging to answer, because receptor overexpression (Avra-
hamandYarden,2011;Pedersenetal., 2005),mutationsand trun-
cations (Arkhipov et al., 2013; Bessman et al., 2014), and
antibodies (Li et al., 2005; Schmiedel et al., 2008) can perturb
the conformations adopted by EGFR and have unpredictable
consequences on signaling. We addressed these challenges by
developing a chemical genetic strategy based on targeted chem-
ical crosslinking that allows for the preparation of a clean popula-
tion of full-length receptor dimers, expressed at near-WT (wild-
type) levels, and dimerized using long and flexible crosslinkers
that do not significantly restrict receptor conformations. This
strategy effectively decouples EGFR dimerization from other2594 Cell Reports 22, 2593–2600, March 6, 2018EGF-induced conformation changes and
dynamics, allowing us to conclude that
the critical function of EGF in Ras signal
transduction is not limited to promoting
the formation of a phosphorylated EGFRdimer, but also promoting receptor dynamics, conformations, or
oligomeric states necessary for downstream signaling.
RESULTS
A Chemical Genetic System for Preparing Full-Length
EGFR Dimers without Ligand
To decouple EGF-induced receptor dimerization from other
EGF-induced conformation changes, we sought to exploit the
equilibrium between monomers and inactive dimers on resting
cells. We hypothesized that selectively reducing the off rate of
EGFR dimers would stimulate autophosphorylation rates suffi-
cient to overcome high endogenous levels of background phos-
phatase activity (Kleiman et al., 2011), thereby generating
phosphorylated receptor dimers. First, we modified the N termi-
nus of full-length EGFR with a flexible linker and a SNAP-tag,
which rapidly forms a covalent bond with benzyl guanine (BG),
as the chemical dimerization domain. When this construct was
stably expressed in HEK293 cells at physiological levels, we
found that it was efficiently activated by the addition of nanomo-
lar concentrations of EGF (Figure 1D). For the chemical dimer-
izer, we incorporated BG at the 50-hydroxyl of double-stranded
DNA molecules (DNA-BG)2, (20-mer; approximate length,
6.8 nm; Figure 1C). Addition of (DNA-BG)2 to live cells for 5 or
30 min resulted in a higher molecular weight band by western
blot, consistent with a trapped dimeric species (Figures 1D
and S1). Blotting for phosphorylation of tyrosine 1068 confirmed
that the kinase domains of trapped dimers were active. Strik-
ingly, we also observed pronounced differences in phosphory-
lated Erk between EGF-stimulated and trapped dimer receptors
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Figure 2. Quantitative Comparison of Tyrosine Phosphorylation
after Dimerization by EGF or (DNA-BG)2
(A) DNA-dimerized receptors can be revealed by PAGE without boiling or can
be boiled to reveal a monomer for direct comparison to EGFR monomers.
d, dimer; m, monomer; RT, room temperature.
(B) Representative western blot of boiled lysates from cells treated with serum-
freemedia (nt, no treatment), 8 nM EGF or 2 mM (DNA-BG)2 at various tyrosines.
(C) Mean fold increase of total EGFR and phosphotyrosines upon EGF or (DNA-
BG)2 treatment compared to no treatment control (n = 3; error bars indicate SD).(Figure 1D). Consistently, and in multiple cell lines, we observed
strong Erk and Akt signaling from EGF-stimulated SNAP-EGFR,
and no signaling above background in the presence of (DNA-
BG)2 (Figure S1). These results suggest that selective stabiliza-
tion of an EGFR dimer is sufficient to stimulate kinase activity
independent of additional conformational changes associated
with EGF binding. However, receptor phosphorylation alone
did not generate Ras-MAPK signaling.
Trapped EGFR Dimers Are Phosphorylated to a Similar
Extent as EGF-Activated EGFR
Differences in EGFR phosphorylation levels between (DNA-BG)2
and EGF stimuli, as well as the pattern of phosphorylation (Ronan
et al., 2016), could explain differences in downstream Erk activa-
tion. This hypothesis could be tested by quantitative western
blotting, but quantitative comparison can be challenging be-
tweenmonomeric and crosslinked species, because large differ-
ences in molecular weight impact the transfer efficiency of
proteins (Towbin et al., 1979). We therefore selectively melted
(DNA-BG)2 crosslinks by boiling samples after cell lysis but prior
to SDS-PAGE (Figure 2A).
Using the concentration of EGF and (DNA-BG)2 in Figure 1D,
which gave EGFR phosphorylation in both conditions but Erk
phosphorylation only with EGF, we used quantitative western
blotting to compare the phosphorylation levels of a suite of tyro-
sines: Y1045, Y1068, Y1086, and Y1173. Notably, we observed
phosphorylation to a similar extent for both conditions (Figures2B and 2C) at a time point and EGF concentration sufficient for
propagation of downstream signals. Increasing the concentra-
tion of (DNA-BG)2 gives a similar result, illustrating the cross-
linker was working near saturating conditions (Figure S2).
Phosphorylated EGFR Dimers Are Not Sufficient to
Stimulate Ras Activation
Mechanistically, several steps occur between the formation of a
phosphorylated EGFR dimer and Erk activation. We therefore
sought to identify the specific step at which the signaling capac-
ity of EGF- and (DNA-BG)2-stimulated dimers diverged. Because
Erk activation requires Ras-GTP formation, we first investigated
whether signaling breakdown occurred at or before the level of
Ras activation. To evaluate the activation status of Ras, we
used the Ras-binding domain of Raf, which selectively binds
Ras-GTP, to pull down GTP-bound activated Ras from whole-
cell lysates. We used the same concentrations of EGF and
(DNA-BG)2 as in our earlier assays and confirmed that, while
EGF and (DNA-BG)2 stimulated similar levels of Y1068 phos-
phorylation after 5 min, only EGF-activated EGFR was capable
of activating Erk signaling. Analyzing the same lysates for Ras
activation, we observed efficient pulldown of Ras-GTP in EGF-
treated cells, while little to no Ras-GTP was detected in cells
treated with (DNA-BG)2 (Figures 3A and 3B). This was particu-
larly surprising, given that Y1068 is widely considered the pri-
mary site responsible for recruiting the Grb2/Sos complex that
activates Ras (Yamauchi et al., 1997). Thus, phosphorylated
EGFR dimers are not sufficient to activate Ras.
Trapped EGFR Dimers Recruit Key Adaptor Proteins for
Ras Signaling
An inability to activate Ras could be explained by an inability of
phosphorylated EGFR to recruit core signaling adaptors such
as SOS, Shc, and Grb2. We therefore investigated adaptor
recruitment to EGF-stimulated and trapped dimer receptors us-
ing co-immunoprecipitation. We treated SNAP-EGFR-express-
ing cells with EGF or (DNA-BG)2 to generate similar levels of
phosphorylated receptor, immunoprecipitated the total EGFR,
and then compared the quantity of adaptor proteins that co-
precipitated after 5min. Surprisingly, we did not observe a differ-
ence in the quantity of precipitated Grb2, SOS, and Shc between
receptors stimulated with EGF or (DNA-BG)2, despite striking
changes in the level of Ras-GTP observed under the same con-
ditions (Figures 3C–3F). These results show that differential
recruitment of core adaptor proteins to EGFR cannot explain
the differences in Ras signaling between our two conditions.
The Structure and Charge of the Crosslinker Do Not
Significantly Impact EGFR Transphosphorylation or
Signal Propagation
Given these surprising findings, we next investigated whether
(DNA-BG)2 was contributing to the lack of Ras signaling in
trapped EGFR dimers. Adding the reagents sequentially, with
(DNA-BG)2 followed by EGF, resulted in Erk and Akt activation
(Figure S2), suggesting that (DNA-BG)2 was not broadly inacti-
vating EGFR. Next, we removed both charge and rigidity from
the dimerizer by substituting the nucleic acid portion of (DNA-
BG)2 with a highly flexible and uncharged polyethylene glycolCell Reports 22, 2593–2600, March 6, 2018 2595
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Figure 3. Trapped EGFR Dimers Recruit Adaptors with Similar Stoichiometry to EGF-Stimulated Cells but Do Not Activate Ras
(A) Representative western blot showing lysates from cells treatedwith either 8 nMEGF, 2 mM (DNA-BG)2, or serum-freemedia (mock) for 5min. The same lysates
were used in a RasGTP pull-down, and samples were blotted for total Ras.
(B) Mean RasGTP levels in each treatment compared to negative control (n = 3; error bars indicate SD).
(C) Representative blot of Grb2 co-immunoprecipitation (coIP) with EGFR on lysates from treated cells.
(D) Representative blot of SOS coIP with EGFR.
(E) Representative blot of Shc coIP with EGFR.
(F) Quantification of adaptor coIP in treated cells compared to negative controls. Signals for each adaptor were normalized to total EGFR levels in the pull-down
sample and plotted as mean fold increase over mock treatment (n = 3; error bars indicate SD).(PEG)molecule. Treatment of SNAP-EGFR-expressing cells with
PEG26-BG2 triggered efficient formation of phosphorylated
dimers but no Erk phosphorylation to levels above control (Fig-
ure S2). Similar results were observed for shorter PEG cross-
linkers, including PEG9 and PEG5. Moreover, crosslinking a
mutant EGFR (V924R), which is unable to form active asym-
metric kinase dimers, did not result in receptor phosphorylation
(Figure S2). These findings demonstrate that crosslinkers acti-
vate the receptor by promoting canonical interactions between
the kinase domains but that they are deficient in their ability to
promote specific EGF-dependent active conformations neces-
sary for Ras activation.
We also considered that the irreversible nature of BG-based
crosslinker dimerization versus reversible EGF-induced dimer-
ization could be a factor in the difference in downstream
signaling. To address this, we made versions of the 20-bp
(DNA-BG)2 with only 6, 8, or 10 contiguous complementary
bases to increase the off rate of the duplex. If the irreversibility
of crosslinks was the explanation of the observed defect
in signaling, we would expect an increase in Erk phosphoryla-
tion per unit of receptor phosphorylation as the duplex melting
temperature approached 37C. However, we did not
observe an increase with any of the mismatched duplexes
(Figure S2).
Phosphorylation of EGFR Dimers Is Not Sufficient for
Nanoscale Oligomer Formation
Our findings demonstrate that, when EGFR dimers are trapped
with linkers that do not significantly constrain receptor confor-
mation, they can autophosphorylate and recruit key signaling2596 Cell Reports 22, 2593–2600, March 6, 2018adapters such as SOS but, surprisingly, do not stimulate Ras.
We therefore sought to better understand how trapped recep-
tor dimers might differ from EGF-induced complexes in events
downstream of receptor phosphorylation, such as oligomeriza-
tion and trafficking. We investigated this question by imaging
cells treated with (DNA-BG)2 or EGF using stochastic optical
reconstruction microscopy (STORM). We used an EGFR
construct with a photoswitchable fluorescent protein (mEos
3.2) fused to the C terminus to resolve oligomers that might
only be visible by imaging below the diffraction limit and ex-
pressed this construct at levels similar to those of receptors
in previous experiments (Figure S1). We observed that, upon
the addition of (DNA-BG)2 to SNAP-EGFR-mEos-expressing
cells, the spatial arrangement of receptors was similar to that
of unstimulated controls, whereas receptors stimulated with
EGF led to rapid accumulation of bright foci after 10 min (Fig-
ures 4A and S3). We quantified images of cells treated with
media alone, EGF, or (DNA-BG)2 and constructed pairwise
distance histograms for each condition. A peak in the histo-
gram indicates an increase in receptor local density compared
to random at a given length scale. Compared to untreated
cells, we found an increase in the histogram height (indicative
of increased dimers and small oligomers) as well as width
(indicative of the formation of larger oligomers) in cells treated
with EGF. In contrast, the analysis of receptor distribution in the
(DNA-BG)2-treated cells showed only a modest increase in
histogram height, consistent with an increased dimer fraction,
but no increase in histogram width, indicative of no change in
the size of clusters when compared to untreated cells
(Figure 4B).
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Figure 4. Trapped EGFR Dimers Do Not Form Nanoscale Spatial Intermediates or Traffic to Clathrin-Coated Pits
(A) Representative images of HEK293-SNAP-EGFR-mEos cells incubated with serum-free media (mock), 8 nM EGF or 2 mM (DNA-BG)2 for 10 min and then
imaged by STORM. Scale bars, 10 mm.
(B) Pairwise correlation analysis of STORM images graphed as median and standard error (n = 10 cells per condition).
(C) Representative images of single-molecule IP of SNAP-EGFR-EGFP cells treated with biotin (bt)-EGF or bt-(DNA-BG)2 for 5 min. Ligand-bound receptors from
lysates were immobilized on neutravidin-coated slides and imaged. EGFR monomers (m) appear as blue spots, dimers (d) appear as pink spots, and clusters (c)
appear as larger yellow spots.
(D) Mean monomer, dimer, and cluster populations of EGFR graphed as a percentage of the sample (n = 3 independent experiments; error bars indicate SD).
(E) Representative EGF-biotin-treated sample with counts of relative intensity per molecule. The blue shaded region represents the monomer portion, the green
shaded region represents the dimer portion, and zoom represents the cluster portion. The average number of EGFR molecules per cluster was estimated by
dividing the average intensity of the clusters by the intensity of a monomer.
(F) TIRF images of HEK293 cells co-transfected with SNAP-EGFR-EGFP and clathrin-light chain-dsRed after treatment with 8 nM EGF, 2 mMDNA, or serum-free
media at 15 min. Scale bar, 1 mm.
(G) Enrichment of SNAP-EGFR-EGFP at clathrin-coated pits over time after treatment with 8 nM EGF, 2 mM (DNA-BG)2, or serum-free media graphed as mean
and SD (n = 10 cells per condition).To further investigate the degree of oligomerization, we per-
formed single-molecule precipitation of SNAP-EGFR-EGFP
receptors treated with biotinylated EGF or biotinylated (DNA-
BG)2 after 5 min. We precipitated Triton X-100-disrupted cells
onto neutravidin-coated slides as previously described (Lee
et al., 2013) to immobilize ligand-bound receptor complexes,
and we imaged the intensity of individual fluorescent spots as
a proxy for the number of EGFRmolecules in each complex (Fig-
ure 4C). We observed an increased ratio of dimers to monomers
in both conditions compared to controls but uniquely observed
the formation of multiple brighter spots only when cells were
treated with biotinylated-EGF (Figure 4D). Comparing the fluo-
rescence intensity of these spots to those of the putative mono-
mer and dimer peaks suggested an average cluster size of
approximately 7–15 molecules for EGF-stimulated receptors
(Figure 4E) after 5 min.In addition to studying receptor arrangements at fixed
time points, we also imaged the dynamic reorganization
of EGFR on live cells. To do so, we used total internal
reflection fluorescence (TIRF) microscopy to follow the
EGFR trafficking in real time, using clathrin-coated pits as a
frame of reference. Although non-clathrin mediated endocy-
tosis may contribute to EGFR dynamics under certain
conditions, we found that a significant fraction of EGF-stimu-
lated receptors were recruited to clathrin-coated pits at the
EGF concentration used in our studies, whereas the localization
of (DNA-BG)2-treated receptors was largely unchanged
compared to controls over the course of 20 min (Figures 4F,
4G, and S4). Therefore, EGF triggers conformational changes
in the EGFR that are necessary for the oligomerization of
phosphorylated receptors and their reorganization on live-cell
membranes.Cell Reports 22, 2593–2600, March 6, 2018 2597
DISCUSSION
If EGFR oligomerization and other cell-surface dynamics are
necessary for efficient MAPK signal transduction, how might
they be coupled to Ras activity? EGFR oligomerization could
stimulate Ras activity by concentrating Ras and SOS in common
signaling complexes, thereby increasing their effective molarity
relative to broadly distributed GAPs, and cooperatively stimu-
lating the formation of Ras-GTP. Consistent with this model,
Ras dimerization and nanoclustering have been shown to affect
downstream Erk signaling (Nan et al., 2015; Tian et al., 2007;
Zhou et al., 2014). Alternatively, EGF bindingmay cause changes
in EGFR transmembrane conformation associated with clus-
tering and the formation of lipid microdomains required for
signaling. For example, EGFR clusters have been shown to co-
localize with membrane regions enriched for PIP2(4,5) (Laketa
et al., 2014), and the GEF activity of SOS can be modulated by
charged lipids, including PIP2(4,5) (Gureasko et al., 2008; Zhao
et al., 2007).
Independent of the detailed mechanism, our findings have
important implications for understanding the regulation of
Ras—and, possibly, other signaling molecules—by EGFR. We
can conclude that conformational changes and/or other pro-
cesses associated with EGF binding are necessary for oligomer
formation and that these higher order EGFR oligomers may be
more potent activators of Ras, on a molecule-to-molecule
basis, when compared to phosphorylated dimers. Such EGF-
dependent formation of EGFR nanoclusters may add an addi-
tional layer of spatial regulation to growth factor signaling,
which aligns with an emerging view of how Ras regulates
downstream pathways, through the formation of similar higher
order species. Our findings also emphasize that not all EGFR
dimers (or oligomers) are the same, and, depending on the initi-
ating signal, receptor activation may evolve very differently. For
example, a recent elegant dissection of structural and func-
tional properties of EGFR dimers induced by different ligands
suggests that more stable receptor dimers induce more tran-
sient profiles of receptor phosphorylation and downstream
pathway activation, presumably by being long lived enough to
recruit negative-feedback regulators (Freed et al., 2017). Our
findings argue that, in addition to the kinetics of receptor
activation, the spatial distribution of receptors following their
activation is a critical determinant of downstream signal propa-
gation. Long-lived trapped dimers are signaling deficient not
because they fail to accumulate substantial phosphorylation
and recruit adapters but, perhaps, because tertiary or quater-
nary interaction are structurally incompatible with subsequent
organization into effective signaling platforms. Finally, our
results demonstrate that receptor activation and signal trans-
duction can be mechanistically decoupled. This finding has
important implications for the development of future therapeu-
tics, which could specifically target receptor organization rather
than activation to modulate signal transduction through specific
pathways.EXPERIMENTAL PROCEDURES
Details are provided in the Supplemental Information.2598 Cell Reports 22, 2593–2600, March 6, 2018Cell Signaling Assays
Cells stably expressing SNAP-EGFRwere grown to 70%–80%confluency and
then serum starved for 6–8 hr prior to stimulus with EGF or (DNA-BG)2 at 37
C,
lysed, and prepared for western blots. For quantitative western blotting, sec-
ondary antibodies conjugated to either Alexa Fluor 680 or DyLight 800 were
used, and blots were imaged on a LI-CORBiosciences imaging system. Scans
were quantified and analyzed by densitometry. Measurements were normal-
ized to loading controls and shown as the mean and SD of 3 independent
experiments.
STORM
HEK293-SNAP-EGFR-mEos cells were serum starved for 6 hr and then incu-
batedwith the indicated stimuli at 37C for 10min. Cells were fixed and imaged
with an inverted microscope using TIRF illumination, 1003magnification, and
a 561-nm laser at 60 Hz. Once every 10 frames, mEos was converted from
green to red state with 405-nm illumination. Images from 10 cells per condition
were corrected for blinking as previously described (Puchner et al., 2013), and
the molecular positions were then used to calculate all the pairwise distances
as previously described (van Lengerich et al., 2017).
Single-Molecule IP
HEK293-SNAP-EGFR-EGFP cells were treated with 8 nm of EGF-biotin or
2 mM of (BG-DNA)2-biotin for 5 min at 37
C, and then lysed with 1% Triton
X-100 buffer. Lysates were incubated on neutravidin-coated PEG slides and
imaged by TIRF microscopy. Over 3 independent experiments, monomer,
dimer, and cluster populations were identified by bleaching steps and analysis
of pixel intensity histograms.
Clathrin Colocalization
HEK293 cells were transfected with SNAP-EGFR-EGFP and clathrin light
chain-dsRed using Lipofectamine 2000. Cells were imaged 48 hr later, live
at 37C with various stimuli. SNAP-EGFR-EGFP enrichment at clathrin struc-
tures was calculated as the difference between the average fluorescence in-
side and outside regions enriched for dsRed. Each condition represents
10 cells pooled across 7 independent experiments.
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